Where can I find the specific financial results for Gilead Sciences for the period ended December 31, 2013?

The specific financial results are detailed in the press release issued by Gilead Sciences on February 4, 2014, which is filed as Exhibit 99.1 to this 8-K report. You will need to refer to that exhibit for the detailed numbers.

What is the difference between the GAAP and non-GAAP financial information mentioned?

GAAP (Generally Accepted Accounting Principles) are the standard accounting rules in the U.S. Non-GAAP financial information is a supplemental measure used by management, which may exclude certain items. Gilead states that management uses this non-GAAP information internally and believes it is useful for investors. However, non-GAAP information is not prepared under comprehensive accounting rules and should be used in conjunction with, and not as a substitute for, GAAP results. A reconciliation between GAAP and non-GAAP figures is provided in the press release.

Does this 8-K filing make any new disclosures about Gilead's business operations or strategic direction?

This 8-K filing is primarily focused on the announcement of financial results. It does not contain new disclosures about specific business operations, strategic initiatives, or material events beyond the financial performance update for the quarter and year ended December 31, 2013.

Are the financial results in this filing subject to review under Section 18 of the Securities Exchange Act?

No, the information furnished in this Form 8-K and its exhibits is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities under that section.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on February 4, 2014, to announce its financial results for the fourth quarter and full year ended December 31, 2013. The report primarily references a press release containing these results, which includes both GAAP and non-GAAP financial information. Investors should note that while management finds the non-GAAP figures useful for internal planning and comparative analysis, these measures are not prepared under comprehensive accounting rules and should be used to supplement, not replace, GAAP-based financial statements. The key takeaway for investors is the availability of detailed fourth quarter and full-year 2013 financial performance data. While the 8-K itself does not contain the specific numbers, it directs stakeholders to the accompanying press release (Exhibit 99.1) for a full breakdown. This includes a reconciliation between GAAP and non-GAAP figures, which is crucial for a complete understanding of Gilead's financial condition and operational results as presented by management.

Key Highlights

1Gilead Sciences announced its Q4 and Full Year 2013 financial results on February 4, 2014, via an 8-K filing.
2The 8-K filing incorporates a press release (Exhibit 99.1) containing the detailed financial results.
3Both GAAP and non-GAAP financial metrics were presented for the periods ended December 31, 2013, and 2012.
4Management believes non-GAAP financial information provides useful insights for investors.
5Investors are directed to the press release for a reconciliation between GAAP and non-GAAP financial data.
6The information furnished in the 8-K and exhibit is not considered 'filed' for Section 18 purposes.
7The filing serves as a notification mechanism for the release of material financial information.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Feb 4, 2014)

Summary

Key Highlights

Frequently Asked Questions